EUR 0.27
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.01 EUR | 100.0% |
2022 | -3726.80 EUR | -490268.42% |
2021 | -0.76 EUR | -4.11% |
2020 | -0.73 EUR | 45.93% |
2019 | -1.35 EUR | -33.66% |
2018 | -1.01 EUR | -260.32% |
2017 | 0.63 EUR | 137.72% |
2016 | -1.67 EUR | -59.05% |
2015 | -1.05 EUR | 26.06% |
2014 | -1.42 EUR | -300.0% |
2013 | 0.71 EUR | -18.39% |
2012 | 0.87 EUR | 229.85% |
2011 | -0.67 EUR | -42.55% |
2010 | -0.47 EUR | 11.32% |
2009 | -0.53 EUR | -212.77% |
2008 | 0.47 EUR | 175.81% |
2007 | -0.62 EUR | -34.78% |
2006 | -0.46 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.00 EUR | 0.0% |
2023 Q2 | -200.00 EUR | 0.0% |
2023 Q4 | -23.90 EUR | 0.0% |
2023 FY | - EUR | 96.89% |
2022 FY | - EUR | 51.32% |
2022 Q2 | -0.32 EUR | 0.0% |
2022 Q4 | -526.80 EUR | 0.0% |
2021 Q2 | -0.41 EUR | 0.0% |
2021 Q4 | -0.34 EUR | 0.0% |
2021 FY | - EUR | -4.11% |
2020 FY | - EUR | 45.93% |
2020 Q4 | -0.39 EUR | 0.0% |
2020 Q2 | -0.34 EUR | 0.0% |
2019 Q2 | -0.87 EUR | 0.0% |
2019 Q4 | -0.48 EUR | 0.0% |
2019 FY | - EUR | -33.66% |
2018 Q2 | -0.39 EUR | 0.0% |
2018 Q4 | -0.62 EUR | 0.0% |
2018 FY | - EUR | -260.32% |
2017 Q4 | 1.03 EUR | 0.0% |
2017 FY | - EUR | 137.72% |
2017 Q2 | -0.42 EUR | 0.0% |
2016 Q4 | -1.24 EUR | 0.0% |
2016 Q2 | -0.42 EUR | 0.0% |
2016 FY | - EUR | -59.05% |
2015 FY | - EUR | 26.06% |
2015 Q4 | -0.52 EUR | 0.0% |
2015 Q2 | -0.53 EUR | 0.0% |
2014 Q4 | -0.76 EUR | 0.0% |
2014 Q2 | -0.66 EUR | 0.0% |
2014 FY | - EUR | -300.0% |
2013 Q2 | 1.48 EUR | 0.0% |
2013 Q4 | -0.78 EUR | 0.0% |
2013 FY | - EUR | -18.39% |
2012 Q1 | 0.21 EUR | 0.0% |
2012 FY | - EUR | 229.85% |
2012 Q4 | 0.18 EUR | -14.29% |
2012 Q2 | 0.21 EUR | 0.0% |
2012 Q3 | 0.21 EUR | 0.0% |
2011 Q4 | 0.21 EUR | 231.25% |
2011 Q1 | -0.16 EUR | 0.0% |
2011 Q2 | -0.16 EUR | 0.0% |
2011 FY | - EUR | -42.55% |
2011 Q3 | -0.16 EUR | 0.0% |
2010 FY | - EUR | 11.32% |
2010 Q2 | -0.12 EUR | 0.0% |
2010 Q1 | -0.12 EUR | 0.0% |
2010 Q3 | -0.12 EUR | 0.0% |
2010 Q4 | -0.16 EUR | -33.33% |
2009 Q1 | -0.13 EUR | 0.0% |
2009 FY | - EUR | -212.77% |
2009 Q3 | -0.13 EUR | 0.0% |
2009 Q2 | -0.13 EUR | 0.0% |
2009 Q4 | -0.12 EUR | 7.69% |
2008 Q4 | -0.13 EUR | -218.18% |
2008 FY | - EUR | 175.81% |
2008 Q1 | 0.11 EUR | 0.0% |
2008 Q2 | 0.11 EUR | 0.0% |
2008 Q3 | 0.11 EUR | 0.0% |
2007 Q3 | -0.17 EUR | 0.0% |
2007 Q4 | 0.11 EUR | 164.71% |
2007 FY | - EUR | -34.78% |
2007 Q2 | -0.17 EUR | 0.0% |
2007 Q1 | -0.17 EUR | 0.0% |
2006 Q4 | -0.17 EUR | -54.55% |
2006 FY | - EUR | 0.0% |
2006 Q3 | -0.11 EUR | 0.0% |
2006 Q2 | -0.11 EUR | 0.0% |
2006 Q1 | -0.11 EUR | 0.0% |
2005 Q4 | -0.11 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
ABIONYX Pharma SA | -0.12 EUR | 90.417% |
ABIVAX Société Anonyme | -3.43 EUR | 99.665% |
Adocia SA | -1.91 EUR | 99.398% |
Aelis Farma SA | -0.39 EUR | 97.051% |
Biophytis S.A. | -12.55 EUR | 99.908% |
Advicenne S.A. | -0.67 EUR | 98.284% |
genOway Société anonyme | 0.17 EUR | 106.765% |
IntegraGen SA | -0.03 EUR | 55.598% |
Medesis Pharma S.A. | -0.80 EUR | 98.563% |
Neovacs S.A. | -0.00 EUR | -360.0% |
NFL Biosciences SA | -0.46 EUR | 97.5% |
Plant Advanced Technologies SA | 0.07 EUR | 116.429% |
Quantum Genomics Société Anonyme | -0.09 EUR | 87.363% |
Sensorion SA | -0.17 EUR | 93.235% |
Theranexus Société Anonyme | -0.88 EUR | 98.693% |
TME Pharma N.V. | -1.34 EUR | 99.142% |
Valbiotis SA | -0.59 EUR | 98.051% |
TheraVet SA | -0.49 EUR | 97.653% |
Valerio Therapeutics Société anonyme | -0.15 EUR | 92.333% |
argenx SE | -4.67 EUR | 99.754% |
BioSenic S.A. | -0.21 EUR | 94.524% |
Celyad Oncology SA | -0.33 EUR | 96.515% |
DBV Technologies S.A. | -0.71 EUR | 98.38% |
Galapagos NV | 3.21 EUR | 100.358% |
Genfit S.A. | -0.58 EUR | 98.017% |
GeNeuro SA | -0.59 EUR | 98.051% |
Hyloris Pharmaceuticals SA | -0.55 EUR | 97.909% |
Innate Pharma S.A. | -0.09 EUR | 87.779% |
Inventiva S.A. | -2.43 EUR | 99.527% |
MaaT Pharma SA | -1.73 EUR | 99.335% |
MedinCell S.A. | -0.88 EUR | 98.693% |
Nanobiotix S.A. | -1.08 EUR | 98.935% |
Onward Medical N.V. | -1.20 EUR | 99.042% |
Oryzon Genomics S.A. | -0.06 EUR | 79.129% |
OSE Immunotherapeutics SA | -1.18 EUR | 99.025% |
Pharming Group N.V. | -0.01 EUR | 20.69% |
Poxel S.A. | -0.91 EUR | 98.736% |
GenSight Biologics S.A. | -0.54 EUR | 97.87% |
Transgene SA | -0.22 EUR | 94.773% |
Financière de Tubize SA | 1.98 EUR | 100.581% |
UCB SA | 1.81 EUR | 100.635% |
Valneva SE | -0.73 EUR | 98.425% |
Vivoryon Therapeutics N.V. | -1.12 EUR | 98.973% |